185 related articles for article (PubMed ID: 8413459)
1. Pathogenesis of Graves' ophthalmopathy.
Bahn RS; Heufelder AE
N Engl J Med; 1993 Nov; 329(20):1468-75. PubMed ID: 8413459
[No Abstract] [Full Text] [Related]
2. Cytokines in the evolution of Graves' ophthalmopathy.
Natt N; Bahn RS
Autoimmunity; 1997; 26(2):129-36. PubMed ID: 9546815
[TBL] [Abstract][Full Text] [Related]
3. Immunology of Graves' ophthalmopathy.
Heufelder AE; Spitzweg C
Dev Ophthalmol; 1999; 30():24-38. PubMed ID: 10627914
[No Abstract] [Full Text] [Related]
4. Increased activated T-lymphocytes and normal thyrotropin receptor antibody levels in Graves' disease in long-term remission.
Peakman M; Hussain M; Cundy T; Vergani D
J Clin Lab Immunol; 1989 Sep; 30(1):1-5. PubMed ID: 2577115
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and treatment of the ophthalmopathy associated with Graves' disease.
Velkeniers B; Salu P
Bull Soc Belge Ophtalmol; 1992; 245():9-14. PubMed ID: 1344754
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the presence of a functional TSH-receptor in retroocular fibroblasts from patients with Graves' ophthalmopathy.
Heufelder AE; Bahn RS
Exp Clin Endocrinol; 1992; 100(1-2):62-7. PubMed ID: 1361450
[No Abstract] [Full Text] [Related]
7. Retroocular fibroblasts: important effector cells in Graves' ophthalmopathy.
Bahn RS; Heufelder AE
Thyroid; 1992; 2(1):89-94. PubMed ID: 1525575
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of Graves' ophthalmopathy: recent controversies and progress.
Heufelder AE
Eur J Endocrinol; 1995 May; 132(5):532-41. PubMed ID: 7749490
[No Abstract] [Full Text] [Related]
9. Pathogenesis of Graves' ophthalmopathy.
Gorman CA
Thyroid; 1994; 4(3):379-83. PubMed ID: 7833680
[No Abstract] [Full Text] [Related]
10. [Immunologic analysis of Graves' ophthalmopathy and ophthalmic Graves' disease].
Liao ZQ
Zhonghua Yan Ke Za Zhi; 1990 May; 26(3):162-4. PubMed ID: 2144488
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of Graves' ophthalmopathy--current understanding.
Wiersinga WM; Prummel MF
J Clin Endocrinol Metab; 2001 Feb; 86(2):501-3. PubMed ID: 11157999
[No Abstract] [Full Text] [Related]
12. Etiopathogenesis of Graves' disease.
Karasek M; Lewinski A
Neuro Endocrinol Lett; 2003; 24(3-4):161-6. PubMed ID: 14523350
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent effect of cyclosporin-A on the TSH-receptor antibody synthesis in patients with Graves' disease.
Balázs C; Kiss E; Farid NR
Acta Med Hung; 1988; 45(1):43-52. PubMed ID: 3412862
[TBL] [Abstract][Full Text] [Related]
14. [Immunopathology of Graves'-Basedow disease].
Baj Z; Ferenc T; Lewiński A
Postepy Hig Med Dosw; 1997; 51(5):531-46. PubMed ID: 9489453
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin receptor autoantibodies in Graves' disease.
Schott M; Scherbaum WA; Morgenthaler NG
Trends Endocrinol Metab; 2005 Jul; 16(5):243-8. PubMed ID: 15950483
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining of normal and Graves' extraocular muscle.
Tallstedt L; Norberg R
Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):175-84. PubMed ID: 2448263
[TBL] [Abstract][Full Text] [Related]
17. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.
Ginsberg J; von Westarp C
CMAJ; 1986 May; 134(10):1141-7. PubMed ID: 2421862
[TBL] [Abstract][Full Text] [Related]
18. Immunopathology of Graves' disease.
Volpé R
Fed Proc; 1979 Nov; 38(12):2611-2. PubMed ID: 227750
[No Abstract] [Full Text] [Related]
19. Interaction of lymphocytes and thyrocytes in Graves' disease and nonautoimmune thyroid diseases in immunohistochemical and ultrastructural investigations.
Ben-Skowronek I; Sierocinska-Sawa J; Szewczyk L; Korobowicz E
Horm Res; 2009; 71(6):350-8. PubMed ID: 19506393
[TBL] [Abstract][Full Text] [Related]
20. Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease.
Bahn RS
J Clin Endocrinol Metab; 2003 May; 88(5):1939-46. PubMed ID: 12727937
[No Abstract] [Full Text] [Related]
[Next] [New Search]
